$MEND Positioned At The Cutting Edge Of Mental Health Mental wellness technology company Nurosene $MEND/$MEND.C is positioned at the leading edge of critical research and innovations, striving to disrupt traditional mental wellness treatments.
By leveraging technological advancements in AI, $MEND is working towards its mission of building the next generation of better and healthier brains.
$MEND’s primary product is the NURO app for mobile devices. The app includes many features that work towards improving adaptability, long-term memory, cognitive flexibility, and working memory. With the new version of the app expected to launch in March 2022, I’m excited to see how $MEND has improved the application and added more value.
Shares of $MEND have been on a turbulent ride since IPO rising 103%, just to fall 77% from June prices. However, I stand behind the importance of the company’s mission and goals and I think it’s just a matter of time before $MEND builds enough traction to make up for lost ground and surpass previous highs.
$MEND is currently trading at $.68 and is currently valued at an MCAP of $26.89 million.
https://nurosene.com/app